awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37679893-401A836C-3E89-418D-BEC5-3B7756C92450
Q37679893-401A836C-3E89-418D-BEC5-3B7756C92450
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37679893-401A836C-3E89-418D-BEC5-3B7756C92450
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.
P2860
Q37679893-401A836C-3E89-418D-BEC5-3B7756C92450
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37679893-401A836C-3E89-418D-BEC5-3B7756C92450
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d171b5d4dcee5f85a126f2e9bf2bc1b0500126de
P2860
The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus.